Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00523380
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2007-08-30
Brief Title:
Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2009-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-30
First Submit QC Date:
August 30 2007
Study First Post Date:
2007-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-28
Last Update Post Date:
2017-03-01
Last Update Post Date Type:
ACTUAL